https://meetings.asco.org/abstracts-presentations/157344
Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry / Francini, E; Gray, KP; Shaw, G; Evan, C; Hamid, A; Perry, CE; Kantoff, PW; Taplin, ME; Sweeney, C. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - ELETTRONICO. - 36:(2018), pp. 203-203. [10.1200/JCO.2018.36.6_suppl.203]
Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry
Francini, EWriting – Original Draft Preparation
;
2018
Abstract
https://meetings.asco.org/abstracts-presentations/157344
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
